This goal of this observational study is to clarify the variations in the natural course of atypical parkinsonian syndromes (APS, including MSA, DLB, PSP, and CBD), such as the progression rate of motor and non-motor symptoms and characteristic imaging evolution patterns. Establish a comprehensive assessment framework for APS, and develop clinical and biological databases to identify biomarkers with early predictive value.
Study Type
OBSERVATIONAL
Enrollment
500
We did not apply any interventions; only observational research was conducted.
Changshu Hospital Affiliated to Nanjing University of Chinese Medicine
Changshu, Jiangsu, China
RECRUITINGThe second People's Hospital of Huai'an
Huai'an, Jiangsu, China
NOT_YET_RECRUITINGThe First People's Hospial of Kunshan
Kunshan, Jiangsu, China
NOT_YET_RECRUITINGJiangsu Province Official Hospital
Nanjing, Jiangsu, China
NOT_YET_RECRUITINGThe Second Affiliated Hospital of Nantong University
Nantong, Jiangsu, China
NOT_YET_RECRUITINGJiangsu Province (Suqian) Hospital
Suqian, Jiangsu, China
RECRUITINGThe Forth Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China
RECRUITINGThe Second Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China
RECRUITINGThe Second Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, China
NOT_YET_RECRUITINGYancheng Third People's Hospital
Yancheng, Jiangsu, China
RECRUITING...and 10 more locations
Natural disease progression of various atypical parkinsonian syndromes
To observe the differences in the natural disease progression of various atypical parkinsonian syndromes (APS, including MSA, DLB, PSP, and CBD), such as the progression rates of motor and non-motor symptoms and the patterns of imaging evolution. The preliminary study design involves a follow-up period of 3 years, with assessments of clinical phenotypes and/or biomarker changes every 6 months.
Time frame: up to 36 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.